XENE stock

Xenon Pharmaceuticals Inc (XENE) earnings · rev $7.5M

These earnings events as JSON? API free 100/day

Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.

This XENE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported XENE revenue for 2025-12-31 was $7.5M. Net income was -$345.9M. XENE currently screens at market cap $2.55B.

When the next XENE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for XENE. We will not invent a beat or miss.

Not investment advice. Full XENE research stays on the stock page; the tape stays on the quote page.

XENE earnings FAQ

What are XENE's latest revenue and net income?

Latest cached Xenon Pharmaceuticals Inc (XENE) revenue for Dec 31, 2025 was $7.5M. Net income was -$345.9M. Statements: https://lician.com/financials/xene

What is XENE's latest diluted EPS?

Latest cached Xenon Pharmaceuticals Inc (XENE) diluted EPS for Dec 31, 2025 was -$4.36.

What period does the latest XENE earnings print cover?

The latest cached Xenon Pharmaceuticals Inc (XENE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

Where are XENE earnings listed?

Cached earnings facts for Xenon Pharmaceuticals Inc (XENE) are listed at https://lician.com/earnings/xene. Statements: https://lician.com/financials/xene

Not investment advice.

Full XENE analysis